跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,683 条关于
“Valorum Biologics LLC”
全部
8,683
临床试验
2,570
药物
1,024
机构
1,824
资讯
3,265
去年
Valorum Biologics Secures Exclusive Rights to Commercialize Formycon's Eylea Biosimilar in North America
9个月前
Lupin Partners with Valorum Biologics for US Launch of Cancer Biosimilar Armlupeg
去年
Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
7年前
FDA Rejects Mallinckrodt's Abuse-Deterrent Roxicodone Reformulation
去年
WuXi Biologics Launches WuXia293Stable Platform to Address Manufacturing Challenges for Complex Biologics
去年
Chime Biologics and Polpharma Biologics Form Strategic Partnership to Accelerate Global Biosimilar Development
3个月前
ADMA Biologics Faces Securities Class Action Lawsuit Over Alleged Undisclosed Related-Party Transactions and Channel Stuffing
6个月前
NorthX Biologics and Demeetra Form Strategic Partnership to Accelerate Biologics Development from Gene to GMP Manufacturing
去年
HCW Biologics Secures $5 Million in Follow-On Financing to Advance Immunotherapy Pipeline
第 1 页,共 327 页
上一页
下一页